| Literature DB >> 33717570 |
Naoko Ose1, Yukiyasu Takeuchi2, Naoto Kitahara3, Akihide Matumura4, Ken Kodama5, Hiroyuki Shiono6, Yoshiyuki Susaki7, Yasunobu Funakoshi8, Hiroyuki Takabatake9, Yasushi Shintani1.
Abstract
BACKGROUND: Solitary pulmonary nodules caused by nontuberculous mycobacteriosis are included as a category of pulmonary nontuberculous mycobacterium disease. Clinical characteristics, treatments and prognosis are not fully known because there are a few related reports.Entities:
Keywords: Solitary; nodule; nontuberculous mycobacterial disease (NTM); pulmonary
Year: 2021 PMID: 33717570 PMCID: PMC7947481 DOI: 10.21037/jtd-20-3108
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Study flow for enrolment of this study describing the numbers of relapse and worsening patients with pathogens.
Patient characteristics
| Cases (n=101) | |
|---|---|
| Sex (male/female) | 59/42 |
| Age | 61.8±11.4 [29–80] |
| Symptom | |
| None | 92 |
| Positive | 9 |
| Cough | 5 |
| Hemosputum | 2 |
| Sputum | 1 |
| Chest pain | 1 |
| Fatigue | 1 |
| Numbers (single/multiple) | 88/13 |
| Locations | |
| Right/left | 72/29 |
| Upper | 41*/10 |
| Middle/lingular | 9*/4 |
| Lower | 23/15 |
| Pathogen | |
| MAC | 77 |
| | 8 |
| | 2 |
| | 1 |
| Only NTM | 13 |
| Diagnosis | |
| Preoperative | 7 |
| Bronchoscopy | 2 |
| CTGB | 1 |
| Gastric juice culture | 1 |
| No details | 3 |
| Postoperative | 94 |
*, one case had two nodules in right upper and middle lobe. MAC, mycobacterium avium complex, M., mycobacterium; NTM, nontuberculous mycobacteriosis; CTGB, computed tomography guided biopsy.
Results of imaging examination
| Cases (n=101) | |
|---|---|
| Chest CT findings | |
| Size (mm) | 19.1±8.2 [7–59] |
| Subpleural | 100 (99.0%) |
| Adjacent pleura | 60 (59.4%) |
| Pleural indentation | 36 (35.6%) |
| Spiculation | 30 (29.7%) |
| Satellite lesion | 14 (13.9%) |
| Necrosis | 13 (12.9%) |
| Air inside | 7 (6.9%) |
| Calcification | 3 (3.0%) |
| FDG-PET | |
| None | 43 |
| Done | 58 |
| SUVmax ≥2.5 | 35 (2.5–13.2) |
| SUVmax <2.5 | 23 (0–2.3) |
CT, computed tomography; FDG-PET, fluorodeoxyglucose-position emission tomography.
Treatment and prognosis
| Cases(n=101) | ||
|---|---|---|
| No. | Treatment period‡‡ | |
| Operation | ||
| Wedge | 87 | |
| Segmentectomy | 3 | |
| Lobectomy | 11 | |
| Approach (thoracotomy/VATS) | 24/77 | |
| Operating time (min) | 112 (37–360) | |
| Blood loss (g) | 5 (0–1,240) | |
| Drainage period (day) | 3 (1–21) | |
| Complications | 7 | |
| Late onset alveolopleural fistula | 3 | |
| Chylothorax | 2 | |
| Pneumonia | 1 | |
| Prolonged air leakage | 1 | |
| Preoperative chemotherapy | 7 | |
| H+R+E | 3 | 1, 3, 9 months |
| H | 1 | 1 months |
| R+E+C+LVFX | 1 | 3 months |
| C+E | 1 | 0.5 months |
| AZM+R+E | 1 | 8 months |
| Postoperative chemotherapy | 21 | |
| R+E+C | 5 | 6, 8, 14, 29 months |
| H+R+E | 4 | 1, 9 months |
| C | 3 | |
| Spafroxasin | 2 | |
| R+E+C+LVFX | 1 | 6 months |
| R+LVFX | 1 | |
| LVFX | 1 | 2 months |
| C+LVFX | 1 | 12 months |
| AZM+R+E | 1 | 12 months |
| C+E | 1 | 0.5 months |
| H+R+E+Z | 1 | |
| Reinfection | ||
| Yes | 10 | |
| Sputum culture positive | 5 | |
| Nodules with other lobe | 5 | |
| Nodules with same lobe | 3 | |
| No | 91 | |
VATS, video assisted thoracic surgery; H, isoniazid; R, rifampicin; E, ethambutol; C, clarithromycin; LVFX, levofroxasin; AZM, azithromycin; Z, pyrazinamide. ‡‡, treatment period was described only in cases it was certain.
Details of worsening case
| Case | Age | Sex | Numbers | Pathogen | Size (mm) | Primary lobe | Procedure | Approach | Postoperative therapy (month) | Period after surgery (month) | At worsening | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sptum culture | Worsening on CT | Worsening lobe | |||||||||||
| 1 | 64 | M | Single | MAC | 10 | LLL | Wedge | VATS | 0 | 1 | + | + | RUL |
| 2 | 80 | M | Single | MAC | 10 | RUL | Wedge | VATS | 0 | 29 | + | + | RLL |
| 3 | 63 | F | Multiple | MAC | 27 | RLL | Wedge | Open | 0 | 45 | + | + | RUL, RLL, LUL, LLL |
| 4 | 54 | M | Single | MAC | 18 | RLL | Wedge | VATS | 0 | 42 | + | − | – |
| 5 | 67 | F | Single | MAC | 14 | RUL | Wedge | VATS | 0 | 24 | + | − | – |
| 6 | 58 | M | Single | MAC | 15 | LLL | Wedge | Open | C | 60 | − | + | RLL |
| 7 | 71 | M | Single | MAC | 40 | LLL | Lobectomy | Open | R+E+C [8] | 18 | − | + | Unkown |
| 8 | 79 | F | Multiple | MAC | 10 | LLL | Wedge | VATS | R+E+C [29] | 6 | − | + | LLL + right lobe |
| 9 | 69 | M | Single | MAC | 37 | RML | Lobectomy | VATS | C+L [12] | 59 | − | + | Unkown |
| 10 | 75 | F | Single | MAC | 13 | RML | Lobectomy | VATS | 0 | 62 | − | + | LUL |
C, clarithromycin; E, ethambutol; L, levofroxasin; LLL, light lower lobe; LUL, left upper lobe; MAC, mycobacterium avium complex; R, rifampicin; RLL; right lower lobe; RUL, right upper lobe; VATS, video assisted thoracic surgery; RML, right middle lobe.
Comparisons between no relapse and worsening cases
| Variables | No relapse | Worsening | P value |
|---|---|---|---|
| Sex | 1.000 | ||
| Female | 35 | 4 | |
| Male | 43 | 6 | |
| Age | 0.225 | ||
| <60 years | 31 | 2 | |
| ≥60 years | 47 | 8 | |
| Numbers | 0.607 | ||
| Single | 69 | 8 | |
| Multiple | 9 | 2 | |
| Symptom | 0.531 | ||
| None | 72 | 9 | |
| Presence | 5 | 1 | |
| Operation | 0.163 | ||
| Wedge | 68 | 7 | |
| Not wedge | 10 | 3 | |
| Approach | 0.697 | ||
| VATS | 60 | 7 | |
| Open | 18 | 3 | |
| Complications | 1.000 | ||
| No | 72 | 10 | |
| Yes | 6 | 0 | |
| Postoperative chemotherapy | 0.226 | ||
| No | 62 | 6 | |
| Yes | 16 | 4 | |